Detailansicht

Wissensnetz

Person

Daniel Fürst (1976-)

Facharzt

Name	Daniel Fürst
Zeit	1976- (Lebensdaten)
Ort	Bad Saulgau (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med. (Univ. Heidelberg) (2005)
Beruf	Facharzt (charakteristischer Beruf) Facharzt für Transfusionsmedizin
Variante	Daniel Siegfried Anton Josef Fürst Daniel Siegfried Anton J. Fürst Daniel Siegfried Anton Fürst Daniel Siegfried A. Fürst Daniel Siegfried Fürst Daniel S. Fürst
Weitere Angaben	Habil. Fachgebiet Transfusionsmedizin an der Univ. Ulm
Datensatztyp	Person
GND-Nummer	129991511
Datensatz-ID	129991511
Beteiligt an alle anzeigen Outcomes of haploidentical transplants with PT-CY versus 10/10 MUD transplants with ATG in Germany Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation Higher risk for chronic graft‐versus‐host disease (GvHD) in HLA‐G mismatched transplants following allogeneic hematopoietic stem cell transplantation : a retrospective study HLA-DRB3/4/5 matching improves outcome of unrelated hematopoietic stem cell transplantation Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors - a retrospective study Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/- in-vitro and express KIR2DL2/DL3 and KIR3DL1 Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/-in-vitro and express KIR2DL2/DL3 and KIR3DL1 Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects Prädiktoren für den Erfolg der unverwandten Blutstammzelltransplantation Etablierung einer immortalen Zelllinie humaner Pankreassternzellen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Daniel Fürst (1976-)

Outcomes of haploidentical transplants with PT-CY versus 10/10 MUD transplants with ATG in Germany

Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients

Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19

Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation

Higher risk for chronic graft‐versus‐host disease (GvHD) in HLA‐G mismatched transplants following allogeneic hematopoietic stem cell transplantation : a retrospective study

HLA-DRB3/4/5 matching improves outcome of unrelated hematopoietic stem cell transplantation

Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors - a retrospective study

Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/- in-vitro and express KIR2DL2/DL3 and KIR3DL1

Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/-in-vitro and express KIR2DL2/DL3 and KIR3DL1

Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects

Prädiktoren für den Erfolg der unverwandten Blutstammzelltransplantation

Etablierung einer immortalen Zelllinie humaner Pankreassternzellen